Dentimus, MB - financials and debts

Company age: 3 y. 3 mo.

Update

Dentimus - Company finances

EUR
2023
From: 2023-06-29
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 28,915 140,853 128,606
Profit before tax 11,662 27,786 3,301
Net profit 11,662 25,854 2,000
Equity 11,662 37,517 24,517
Liabilities 10,935 7,477 3,117
Non-current assets 6,796 8,820 5,708
Current assets 15,801 36,174 21,926
Total assets 22,597 44,994 27,634
Taxes paid
STI taxes 523 398 2,337
Financial indicators
Revenue change y/y - +387.1% -8.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 51.6% 57.5% 7.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 100.0% 68.9% 8.2%
Profit margin Net profit margin. Shows the overall profitability of the company. 40.3% 18.4% 1.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 40.3% 19.7% 2.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.9 0.2 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 28,915 140,853 128,606

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Dentimus - Social security debts

From To Debt, €
2025-04-01 2025-04-09 18.59
2025-03-16 2025-03-17 139.37
2025-03-04 2025-03-15 247.14
2025-03-03 2025-03-03 33.55
2025-03-01 2025-03-02 247.14
2025-02-18 2025-02-26 33.55

Dentimus - VMI tax arrears

From To Overdue, €
2025-04-16 2025-04-18 0.27
2025-04-02 2025-04-10 0.27
2025-03-31 2025-04-01 0.11

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Dentimus, MB (code 306348059) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated revenue of €128.6K and net profit of €2.0K, resulting in a profit margin of 1.6%. Revenue declined by 8.7% year on year, although it remained well above the 2023 level, when turnover was €28.9K for a 185-day period. The strongest year in the series was 2024, with revenue of €140.9K and net profit of €25.9K. Over the three-year period, earnings moved from €11.7K in 2023 to €25.9K in 2024 and then down sharply in 2025. At year-end 2025, total assets stood at €27.6K, equity at €24.5K and liabilities at €3.1K, indicating a strong equity base. The equity ratio was 88.7%, debt-to-equity 0.13, ROE 8.2% and ROA 7.2%. Revenue per employee was €128.6K.